Glaukos Corporation Announces First Quarter 2022 Financial Results
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Day: May 4, 2022
Outset Medical Reports First Quarter 2022 Financial Results
Revenue Grows 33.3% to $30.6 million, Gross Margin expands 13.2 percentage points to 14.5% Year-over-Year SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical,...
CONMED Announces Definitive Agreement to Acquire In2Bones Global, Inc.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. (In2Bones), on a...
KORU Medical Systems Announces 2022 First Quarter Financial Results
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical...
WEED Australia Ltd. is Honored to be Invited and Attend the United in Compassion 2022 Australian Medicinal Cannabis Symposium!
WEED Australia Ltd., w/non-profit arm, The Cannabis Institute of Australia, is attending the United in Compassion Australian Medicinal Cannabis Symposium...
Rhino Biotech to Present at the Planet Microcap Showcase
ANGUILLA, BWI / ACCESSWIRE / May 4, 2022 / Rhino Biotech Limited (OTCPINK:RBRXF), a Biotech Company ("Rhino Biotech" or "the...
Rhino Biotech has acquired cannabis genetics company and a biopharmaceutical company.
ANGUILLA, BRITISH OVERSEAS TERRITORIES / ACCESSWIRE / May 4, 2022 / Rhino Biotech Limited (OTC:RBRXF)294 Heywood House,South Hill1A AI-2640, AnguillaRhino...
IRLAB Announces Invitation to Presentation of the Interim Report for Q1 2022
GOTHENBURG, SWEDEN / ACCESSWIRE / May 4, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB Therapeutics AB (publ) today announced that the...
Number of voting rights as of May 4, 2022
Nicox SASociété anonyme with a registered capital of € 43,223,135 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S....
Renowned Entrepreneur Vinod Ramchandra Jadhav Breaks Ground for the Renovation of Maharashtra Sahitya Parishad Library Cum Study Center
PUNE, INDIA / ACCESSWIRE / May 4, 2022 / Dubai-based entrepreneur Mr. Vinod Ramchandra Jadhav did the ground-breaking for the...
Valneva Initiates Heterologous Booster Trial of Inactivated, COVID-19 Vaccine Candidate
Saint-Herblain (France), May 4, 2022 – Valneva SE, a specialty vaccine company, today announced the initiation of a heterologous booster...
NLS Pharmaceutics Achieves 90% Enrollment Milestone in Quilience(R) Phase 2a Clinical Trial for Patients with Narcolepsy
Since the interim results were released in March, patient enrollment has nearly doubledOf the 60 patients planned for the study,...
Bavarian Nordic to Host First Quarter 2022 Results Conference Call and Webcast
COPENHAGEN, Denmark – May 4, 2022 - Bavarian Nordic A/S (OMX: BAVA) will announce its 2022 first quarter results on...
Xcelerate, Inc. Expands IP with Acquisition of Patent Portfolio
MAULDIN, SC / ACCESSWIRE / May 4, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it signed a purchase...
Top 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and...
Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022
HAMBURG, GERMANY / ACCESSWIRE / May 4, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will...
Umoja Biopharma Presents Data on its Synthetic Cytokine Receptor Platform at the International Society for Cell and Gene Therapy Annual Meeting 2022
RACR-induced cytotoxic innate lymphocytes permit the expansion and differentiation of iPSCs with fewer limitations, leading to a more cost-effective manufacturing...
Marker Therapeutics to Present Four Posters on its T Cell-Based Immunotherapies at the 2022 International Society for Cell & Gene Therapy Annual Meeting
HOUSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of...
NATO Center of Excellence for Military Medicine to Study Brain Scientific’s NeuroCap Device
Brain Scientific partner LOK Corporation will illustrate the advantages of expanding EEG access with Brain Scientific’s neurology productsLAKEWOOD RANCH, Fla.,...
Annual General Meeting of Infant Bacterial Therapeutics
At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 4, 2022, among other things, the following...
